# BEX2

## Overview
BEX2, or brain expressed X-linked 2, is a gene that encodes a protein of the same name, which is part of the brain-expressed X-linked (BEX) gene family. The BEX2 protein is characterized as an intrinsically disordered protein, allowing it to engage in diverse cellular processes, including transcriptional regulation and signaling pathways, particularly within the central nervous system (Fernandez2015Brain; Alvarez2005Characterization). It is predominantly expressed in regions such as the pituitary, cerebellum, and temporal lobe, indicating its potential role in neuronal development and function (Fernandez2015Brain). BEX2 is involved in complex signaling networks, interacting with various proteins and influencing pathways related to cell survival, proliferation, and apoptosis (Naderi2010BEX2; Kazi2015BrainExpressed). Its clinical significance is underscored by its involvement in several cancers, where it can act as either a pro-oncogenic factor or a protective agent, depending on the context (Naderi2019Molecular; Tan2020Silencing).

## Function
BEX2 is a member of the brain-expressed X-linked (BEX) gene family, which is involved in various cellular processes, including transcriptional regulation and signaling pathways. BEX2 is primarily expressed in the central nervous system, with high levels in the pituitary, cerebellum, and temporal lobe, suggesting a role in neuronal development and function (Fernandez2015Brain; Alvarez2005Characterization). BEX2 proteins are intrinsically disordered, allowing them to participate in complex signaling networks and potentially form new protein network hubs (Fernandez2015Brain).

BEX2 interacts with the transcription factor LMO2, enhancing NSCL2-dependent transcriptional activity, which is crucial for embryonal development (Kazi2015BrainExpressed). It is also involved in cellular signaling by binding to multiple partners with low affinity and high specificity, facilitated by its molecular recognition elements (MoREs) (Fernandez2015Brain). BEX2's subcellular localization in both the nucleus and cytoplasm suggests roles in nuclear-cytoplasmic transport and gene regulation (Alvarez2005Characterization).

In healthy human cells, BEX2's expression pattern and interactions indicate its involvement in normal brain physiology, potentially influencing cell survival and proliferation through its participation in signaling pathways (Kazi2015BrainExpressed).

## Clinical Significance
BEX2 is implicated in various cancers, including breast cancer, glioma, and colorectal cancer, due to its role in cell proliferation and apoptosis. In breast cancer, BEX2 overexpression is associated with a subset of estrogen receptor-positive (ER+) tumors and is linked to better responses to tamoxifen therapy. This is potentially due to its involvement in the nerve growth factor (NGF)/nuclear factor-kappa B (NF-κB) pathway, which regulates apoptosis and enhances the antiproliferative effect of tamoxifen (Naderi2019Molecular; Naderi2007BEX2). BEX2 also interacts with transcription factors like c-Jun and p65/RelA, influencing cell cycle progression and survival in breast cancer cells (Naderi2010BEX2).

In glioma, BEX2 has a pro-oncogenic role, promoting cell migration and invasion, and protecting cells from apoptosis through interactions with the JNK and NF-κB pathways (Naderi2019Molecular). In colorectal cancer, silencing BEX2 enhances metastasis by activating the hedgehog signaling pathway, suggesting a protective role against cancer progression (Tan2020Silencing). These findings highlight the clinical significance of BEX2 expression alterations and interactions in cancer, suggesting it as a potential therapeutic target.

## Interactions
BEX2 interacts with several proteins and is involved in various signaling pathways. It is a target gene for transcription factors c-Jun and p65/RelA, which require phosphorylation to bind and activate the BEX2 promoter. BEX2 overexpression increases the nuclear localization of p65, a process dependent on IκBα phosphorylation. Silencing BEX2 reduces phosphorylation of p65 and IκBα, indicating its role in regulating these proteins (Naderi2010BEX2).

BEX2 is necessary for c-Jun phosphorylation and JNK kinase activity, influencing cyclin D1 induction and cell proliferation. It also inhibits PP2A activity, affecting phosphorylation in NF-κB and c-Jun/JNK pathways. BEX2 interacts with ErbB2, where ErbB2 overexpression induces BEX2 expression via c-Jun signaling, suggesting a feedback loop between BEX2, ErbB2, and c-Jun (Naderi2019Molecular).

In intrahepatic cholangiocarcinoma, BEX2 interacts with mitochondrial proteins such as TUFM, HSPD1, IVD, and PECR, suggesting a role in mitochondrial function. BEX2 is also associated with the FEM1B-CUL2 E3 ubiquitin ligase complex, leading to its degradation (Tamai2020BEX2). These interactions highlight BEX2's involvement in transcriptional regulation and signaling pathways across different cancer types.


## References


[1. (Tamai2020BEX2) Keiichi Tamai, Mao Nakamura-Shima, Rie Shibuya-Takahashi, Shin-Ichiro Kanno, Akira Yasui, Mai Mochizuki, Wataru Iwai, Yuta Wakui, Makoto Abue, Kuniharu Yamamoto, Koh Miura, Masamichi Mizuma, Michiaki Unno, Sadafumi Kawamura, Ikuro Sato, Jun Yasuda, Kazunori Yamaguchi, Kazuo Sugamura, and Kennichi Satoh. Bex2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma. Scientific Reports, December 2020. URL: http://dx.doi.org/10.1038/s41598-020-78539-0, doi:10.1038/s41598-020-78539-0. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-78539-0)

[2. (Kazi2015BrainExpressed) Julhash U. Kazi, Nuzhat N. Kabir, and Lars Rönnstrand. Brain-expressed x-linked (bex) proteins in human cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1856(2):226–233, December 2015. URL: http://dx.doi.org/10.1016/j.bbcan.2015.09.001, doi:10.1016/j.bbcan.2015.09.001. This article has 14 citations.](https://doi.org/10.1016/j.bbcan.2015.09.001)

[3. (Naderi2010BEX2) Ali Naderi, Ji Liu, and Luke Hughes-Davies. Bex2 has a functional interplay with c-jun/jnk and p65/rela in breast cancer. Molecular Cancer, 9(1):111, 2010. URL: http://dx.doi.org/10.1186/1476-4598-9-111, doi:10.1186/1476-4598-9-111. This article has 28 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-9-111)

[4. (Naderi2007BEX2) Ali Naderi, Andrew E. Teschendorff, Juergen Beigel, Massimiliano Cariati, Ian O. Ellis, James D. Brenton, and Carlos Caldas. Bex2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-κb inhibition of apoptosis in breast cancer cell lines. Cancer Research, 67(14):6725–6736, July 2007. URL: http://dx.doi.org/10.1158/0008-5472.can-06-4394, doi:10.1158/0008-5472.can-06-4394. This article has 70 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-06-4394)

[5. (Fernandez2015Brain) Eva M. Fernandez, María D. Díaz-Ceso, and Marçal Vilar. Brain expressed and x-linked (bex) proteins are intrinsically disordered proteins (idps) and form new signaling hubs. PLOS ONE, 10(1):e0117206, January 2015. URL: http://dx.doi.org/10.1371/journal.pone.0117206, doi:10.1371/journal.pone.0117206. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0117206)

[6. (Tan2020Silencing) Yinuo Tan, Yeting Hu, Qian Xiao, Yang Tang, Haiyan Chen, Jinjie He, Liubo Chen, Kai Jiang, Zhanhuai Wang, Ying Yuan, and Kefeng Ding. Silencing of brain-expressed x-linked 2 (bex2) promotes colorectal cancer metastasis through the hedgehog signaling pathway. International Journal of Biological Sciences, 16(2):228–238, 2020. URL: http://dx.doi.org/10.7150/ijbs.38431, doi:10.7150/ijbs.38431. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijbs.38431)

[7. (Naderi2019Molecular) Ali Naderi. Molecular functions of brain expressed x-linked 2 (bex2) in malignancies. Experimental Cell Research, 376(2):221–226, March 2019. URL: http://dx.doi.org/10.1016/j.yexcr.2019.02.014, doi:10.1016/j.yexcr.2019.02.014. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2019.02.014)

[8. (Alvarez2005Characterization) Enrique Alvarez, Wenbo Zhou, Samir E. Witta, and Curt R. Freed. Characterization of the bex gene family in humans, mice, and rats. Gene, 357(1):18–28, August 2005. URL: http://dx.doi.org/10.1016/j.gene.2005.05.012, doi:10.1016/j.gene.2005.05.012. This article has 60 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2005.05.012)